Robeco Institutional Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.4M | Sell |
96,368
-7,113
| -7% | -$2.32M | 0.05% | 281 |
|
|
2025
Q1 | $27.9M | Buy |
103,481
+3,487
| +3% | +$942K | 0.05% | 272 |
|
|
2024
Q4 | $23.5M | Buy |
99,994
+26,426
| +36% | +$6.22M | 0.04% | 302 |
|
|
2024
Q3 | $20.2M | Buy |
73,568
+23,898
| +48% | +$6.57M | 0.04% | 331 |
|
|
2024
Q2 | $12.1M | Buy |
49,670
+20,830
| +72% | +$5.06M | 0.03% | 394 |
|
|
2024
Q1 | $4.31M | Buy |
28,840
+4,705
| +19% | +$703K | 0.01% | 580 |
|
|
2023
Q4 | $4.62M | Buy |
24,135
+16,099
| +200% | +$3.08M | 0.01% | 573 |
|
|
2023
Q3 | $1.42M | Sell |
8,036
-19,107
| -70% | -$3.38M | ﹤0.01% | 739 |
|
|
2023
Q2 | $5.16M | Sell |
27,143
-25,615
| -49% | -$4.87M | 0.01% | 548 |
|
|
2023
Q1 | $10.6M | Buy |
52,758
+771
| +1% | +$154K | 0.03% | 429 |
|
|
2022
Q4 | $12.4M | Buy |
51,987
+12,628
| +32% | +$3M | 0.04% | 392 |
|
|
2022
Q3 | $7.88M | Buy |
39,359
+36,948
| +1,532% | +$7.4M | 0.03% | 443 |
|
|
2022
Q2 | $352K | Sell |
2,411
-579
| -19% | -$84.5K | ﹤0.01% | 790 |
|
|
2022
Q1 | $488K | Buy |
2,990
+2,951
| +7,567% | +$482K | ﹤0.01% | 776 |
|
|
2021
Q4 | $7K | Buy |
+39
| New | +$7K | ﹤0.01% | 899 |
|
|
2021
Q3 | – | Sell |
-3,602
| Closed | -$611K | – | 917 |
|
|
2021
Q2 | $611K | Sell |
3,602
-5,208
| -59% | -$883K | ﹤0.01% | 781 |
|
|
2021
Q1 | $1.24M | Sell |
8,810
-5,444
| -38% | -$768K | ﹤0.01% | 712 |
|
|
2020
Q4 | $1.85M | Sell |
14,254
-20,599
| -59% | -$2.67M | ﹤0.01% | 669 |
|
|
2020
Q3 | $5.07M | Sell |
34,853
-25,534
| -42% | -$3.72M | 0.02% | 513 |
|
|
2020
Q2 | $8.94M | Buy |
60,387
+57,870
| +2,299% | +$8.57M | 0.03% | 439 |
|
|
2020
Q1 | $273K | Buy |
+2,517
| New | +$273K | ﹤0.01% | 866 |
|
|
2018
Q4 | – | Sell |
-1,427
| Closed | -$125K | – | 967 |
|
|
2018
Q3 | $125K | Hold |
1,427
| – | – | ﹤0.01% | 935 |
|
|
2018
Q2 | $141K | Hold |
1,427
| – | – | ﹤0.01% | 920 |
|
|
2018
Q1 | $170K | Buy |
+1,427
| New | +$170K | ﹤0.01% | 895 |
|
|
2015
Q3 | – | Sell |
-2,980
| Closed | -$357K | – | 766 |
|
|
2015
Q2 | $357K | Buy |
+2,980
| New | +$357K | ﹤0.01% | 702 |
|